Grand Opening of Prestige Bio Pharmaceuticals Korea Osong Campus IPrestigeBio Pharmaceuticals celebrated the successful completion of GMP facility, Osong Campus I, at their grand opening held September 11 in Osong, South Korea.
Prestige BioPharma Singapore Initiates Listings in Korea Exchange with Samsung Securities
Prestige BioPharma and Samsung Securities, Korea (016360) have entered into a sponsorship and underwriting agreement for listing in Korea Exchange.
Prestige BioPharma and Alvogen Announce License and Supply Agreement
Prestige BioPharma and Alvogen announce License and Supply Agreement: Two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma’s Trastuzumab biosimilar (HD201; Hervelous) in Central and Eastern Europe.
Prestige Bio Pharma Introduces Smart Factories Platform in Korea
Bio Pharmaceuticals, part of the PrestigeBio Group introduces state-of-the-art process system in collaboration with Thermofisher Scientific in Korea – ‘Smart Factory Platform’.